SIN3A Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid repeated freeze-thaw cycles.
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your order. Delivery times may vary depending on the purchase method or location. Please consult your local distributors for specific delivery time estimates.
Synonyms
AW553200 antibody; DKFZP434K2235 antibody; FLJ90319 antibody; Histone deacetylase complex subunit Sin 3a antibody; Histone deacetylase complex subunit Sin3a antibody; KIAA0700 antibody; Kiaa4126 antibody; mKIAA4126 antibody; Paired amphipathic helix protein Sin 3a antibody; Paired amphipathic helix protein Sin3a antibody; Sin 3a antibody; SIN3 homolog A antibody; SIN3 homolog A transcription regulator (yeast) antibody; SIN3 homolog A transcription regulator antibody; SIN3 transcription regulator homolog A antibody; Sin3a antibody; SIN3A protein antibody; SIN3A_HUMAN antibody; Transcriptional co repressor Sin 3A antibody; Transcriptional co repressor Sin3A antibody; Transcriptional corepressor Sin3a antibody; Transcriptional regulator SIN3A antibody
Target Names
Uniprot No.

Target Background

Function
SIN3A acts as a transcriptional repressor. It functions as a corepressor for REST and interacts with MXI1 to repress MYC-responsive genes, effectively antagonizing MYC's oncogenic activities. Furthermore, SIN3A interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. It cooperates with OGT to repress transcription in parallel with histone deacetylation. SIN3A plays a crucial role in the control of circadian rhythms. It is essential for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. SIN3A also cooperates with FOXK1 to regulate cell cycle progression, likely by repressing the expression of cell cycle inhibitor genes. Importantly, SIN3A is required for cortical neuron differentiation and callosal axon elongation.
Gene References Into Functions
  1. AML patients exhibiting high SIN3A expression levels displayed a poorer prognosis compared to those with low expression. The Y325C variant, previously observed in endometrial carcinoma, was also detected in one AML patient. Computational analysis predicted a stability change of -1.433 Kcal/mol, suggesting significant disruption of the protein's secondary structure. PMID: 29764005
  2. The FOXN3-NEAT1-SIN3A complex promotes epithelial-to-mesenchymal transition (EMT) and invasion of breast cancer cells in vitro, as well as dissemination and metastasis of breast cancer in vivo. PMID: 28805661
  3. Haploinsufficiency of SIN3A results in mild intellectual disability by affecting the development of cortical integrity. PMID: 27399968
  4. Two novel translocations leading to the inactivation of RUNX1 and its partners SIN3A and TCF12 have been identified in myeloid leukemia. PMID: 26671595
  5. Research suggests a lack of association between SIN3A gene sequence variants and azoospermia caused by Sertoli cell-only syndrome in humans. PMID: 25395209
  6. Downregulation of miR-202 led to increased expression of its target Mxd1, followed by Mxd1 recruitment to the Sin3A repressor complex and its dimerization with Max. This resulted in enhanced repression of Myc-Max target proteins. PMID: 25611699
  7. Protein pairs significantly correlated with an increased risk of death in non-small cell lung cancer include mSin3A with p16, and c-Myc with mSinA. PMID: 26118188
  8. Aberrantly expressed miR-210 regulates human U251 glioma cells apoptosis and proliferation, partly through direct downregulation of SIN3A protein expression. PMID: 25481483
  9. Bone-marrow-specific deletion of Sin3a revealed that Sin3a-associated HDAC1/2 activity is essential for hematopoietic stem cell homeostasis. PMID: 24763403
  10. SIN3A, typically considered a transcriptional repressor, is required for the induction of gene transcription by the aryl hydrocarbon receptor. PMID: 25305016
  11. EBNA3C binds strongly to BATF/IRF4/SPI1/RUNX3 sites to enhance transcription and recruits RBPJ/Sin3A- and REST/NRSF-repressive complexes to repress p14(ARF) and p16(INK4A) expression. PMID: 24344258
  12. Reducing Sin3A levels significantly increased the invasive behavior of A549 human lung adenocarcinoma cells. These findings indicate that Sin3A is downregulated in various human tumors. PMID: 22890320
  13. The Sin3a complex acts as a context-dependent ISGF3/STAT3 transcriptional switch. PMID: 22783022
  14. Ume6 functions as a negative regulator of ATG8 transcription, acting alongside a histone deacetylase complex including Sin3 and Rpd3 to regulate Atg8 levels. PMID: 22733735
  15. The interplay between SIN3A and STAT3 mediates chromatin conformational changes and GFAP expression during cellular differentiation. PMID: 21779366
  16. Sin3a, HDAC1, and YY1 are co-factors for Gon4l, suggesting that Gon4l may function as a platform for the assembly of complexes that regulate gene expression. PMID: 21454521
  17. Research identifies Sin3A as a regulator of gene expression, survival, and growth in ERalpha-positive breast cancer cells. PMID: 20920219
  18. Sumoylation of ING2 enhances its binding to the Sin3A/HDAC complex, which is required for the regulation of gene transcriptions. PMID: 20676127
  19. The HDAC-Sin3A complex regulates LHR gene transcription. PMID: 12091390
  20. Menin is crucial for recruiting an mSin3A-histone deacetylase complex to repress JunD transcriptional activity. PMID: 14559791
  21. MeCP2 acts as a corepressor of PU.1, likely by facilitating complex formation with mSin3A and HDACs. PMID: 14647463
  22. The transcription corepressor mSin3A interacts with SMN (Survival motor neuron) protein. PMID: 14749338
  23. Results suggest that SHP mediates recruitment of mSin3A-Swi/Snf to the CYP7A1 promoter, resulting in chromatin remodeling and gene repression. PMID: 15314177
  24. p53 antagonizes c-Myb by recruiting mSin3A to down-regulate specific Myb target genes. PMID: 15509555
  25. Data indicate that T-bet can override repressive epigenetic modification through a T-box half-site and dissociation of the mSin3a corepressor from the promoter. PMID: 15684083
  26. Sin3A-mediated deacetylation within the coding regions of active genes is directly linked to the histone methyltransferase activity of Smyd2. PMID: 16805913
  27. Sin3A-mediated deacetylation within the coding regions of active genes is directly linked to the histone methyltransferase activity of Smyd2 [Symd2]. PMID: 16805913
  28. Repression of p53-mediated transcription by adenovirus E1B 55-kDa does not require corepressor mSin3A and histone deacetylases. PMID: 17209038
  29. The attenuated function of SIN3A due to decreased expression levels may result in epigenetic deregulation of growth-related genes through histone acetylation, leading to the tumorigenesis of lung cancer cells. PMID: 17854949
  30. PRMT1-dependent methylation of RUNX1 at arginine residues 206 and 210 abrogates its association with SIN3A. PMID: 18316480
  31. A novel regulatory signaling mechanism of transcriptional control has been identified, where the LHR is derepressed through PKCalpha/ERK-mediated Sp1 phosphorylation, causing the release of the HDAC1/mSin3A complex from the promoter. PMID: 18372343
  32. Results demonstrate that targeted degradation of NFX1-91 by E6/E6AP dissociates the mSin3A/HDAC complex from the hTERT promoter, inducing hTERT transcription. PMID: 18505829
  33. Findings show that SHP and Sin3A play a significant role in adamantyl-substituted retinoid-related induction of cellular apoptosis. PMID: 19509248
  34. These data support a model of repression where actions of ERalpha and Sin3A at the proximal promoter can overcome activating signals at distal or proximal sites, ultimately decreasing gene expression. PMID: 19620290
  35. The transcriptional repressor mSin3A associates with histone deacetylase 1, forming a co-repressor complex. See also PMID (PubMed identifier) 9150133. PMID: 9150134
  36. mSin3A interacts with HDAC2 via the HDAC-interacting domain (HID) of mSin3A. PMID: 9150134

Show More

Hide All

Database Links

HGNC: 19353

OMIM: 607776

KEGG: hsa:25942

STRING: 9606.ENSP00000353622

UniGene: Hs.513039

Subcellular Location
Nucleus. Nucleus, nucleolus. Note=Recruited to the nucleolus by SAP30L.
Tissue Specificity
Expressed in the developing brain, with highest levels of expression detected in the ventricular zone of various cortical regions.

Q&A

What is SIN3A and what is its function in cellular processes?

SIN3A (SIN3 transcription regulator family member A) is a multifunctional transcriptional regulatory protein with a canonical length of 1273 amino acids and a molecular weight of approximately 145.2 kDa in humans. It primarily localizes to the nucleus and traditionally functions as a transcriptional repressor . SIN3A contains paired amphipathic helix (PAH) domains that are critical for protein-protein interactions .

SIN3A forms part of a large multi-subunit repressor complex that includes histone deacetylases HDAC1 and HDAC2, along with SMRT/NCoR1 . This complex is recruited to promoters by sequence-specific DNA binding proteins such as REST, MXI1, and MAD-MAX to repress gene transcription .

Recent research has revealed that SIN3A has context-dependent functions:

  • Acts as a master regulator of STAT transcriptional activity, specifically repressing STAT3 activity while enabling ISGF3-responsive gene transcription

  • Plays a critical role in maintaining T-regulatory cell identity through stabilization of Foxp3 expression

  • Surprisingly functions as a coactivator in certain contexts, such as during TCDD-induced CYP1A1 transcription

What applications are SIN3A antibodies commonly used for in research?

SIN3A antibodies are employed in multiple experimental applications:

ApplicationTypical DilutionsNotes
Western Blot (WB)1:100-1:10000Detects 145-150 kDa band
Immunoprecipitation (IP)0.5-4μg antibody per 200-400μg extractUsed to isolate SIN3A-containing complexes
Chromatin Immunoprecipitation (ChIP)Application-specificCritical for studying SIN3A binding to gene regulatory regions
Immunofluorescence (IF)/ICC1:50-1:5000For subcellular localization studies
Immunohistochemistry (IHC)Application-specificFor tissue expression analysis
ELISAStarting at 1μg/mLFor protein quantification

ChIP applications are particularly valuable for investigating SIN3A's role as a transcriptional regulator by identifying its genomic binding sites and associated proteins .

What are the key considerations when selecting a SIN3A antibody?

When selecting a SIN3A antibody, researchers should consider:

  • Target epitope location: Different antibodies target distinct regions of SIN3A:

    • N-terminal antibodies (AA 1-123)

    • Middle region antibodies

    • C-terminal antibodies

  • Host species and clonality:

    • Rabbit polyclonal: Most common, useful for multiple applications

    • Mouse monoclonal: Higher specificity, valuable for consistent results across experiments

  • Validated applications: Ensure the antibody is validated for your specific application:

    • ChIP-grade antibodies are specifically validated for chromatin immunoprecipitation

    • Some antibodies are validated for multiple applications (WB, IF, ChIP, etc.)

  • Species reactivity: Cross-reactivity with human, mouse, and rat varies between antibodies

How should I design ChIP experiments using SIN3A antibodies?

When designing ChIP experiments with SIN3A antibodies:

  • Antibody selection: Use ChIP-validated antibodies specifically tested for this application

  • Controls:

    • Include an IgG control from the same species as your SIN3A antibody

    • Use positive control primers for known SIN3A binding sites

    • Include negative control primers for regions not bound by SIN3A

  • Experimental approach:

    • For studying repressive functions, examine SIN3A binding at STAT3-responsive genes

    • For activating functions, investigate binding at TCDD-responsive genes like CYP1A1

  • Quantification: Use qPCR with validated primer sets to quantify enrichment:

    • Active Motif's Human Negative Control Primer Set 1 has been validated for qPCR when using SIN3A antibodies on human samples

    • For mouse samples, Mouse Negative Control Primer Set 1 is recommended

What is the optimal protocol for Western blotting with SIN3A antibodies?

For optimal Western blotting with SIN3A antibodies:

  • Sample preparation:

    • Use nuclear extracts for enrichment (SIN3A is primarily nuclear)

    • HeLa nuclear extract can serve as a positive control

  • Electrophoresis conditions:

    • Use 6-8% SDS-PAGE gels to properly resolve the high molecular weight (~145 kDa) protein

    • Include molecular weight markers spanning 100-250 kDa range

  • Antibody dilution:

    • Start with manufacturer's recommended dilution (typically 1:2000-1:10000)

    • Optimize based on signal strength and background

  • Detection considerations:

    • Expected molecular weight: 145-150 kDa

    • Verify specificity using Sin3A knockdown or knockout samples as negative controls

  • Troubleshooting:

    • If detection is problematic, consider using antibodies targeting different epitopes

    • Validated cell lines for Western blotting include HeLa, HSC-T6, NIH/3T3, 4T1, HEK-293, MCF-7, and Jurkat cells

How can I effectively study SIN3A's dual role as both a repressor and activator?

To investigate SIN3A's context-dependent functions:

  • Gene expression analysis:

    • Compare SIN3A knockdown effects on both STAT3-responsive genes (repressive function) and TCDD-inducible genes like CYP1A1 (activating function)

    • Use RNA-seq or qPCR to analyze changes in gene expression profiles

  • Rescue experiments:

    • Perform siRNA knockdown followed by ectopic expression of SIN3A to confirm specificity

    • Research demonstrates that "Expression of human SIN3A efficiently rescued TCDD-induced EROD levels in cells treated with the mouse siRNA when compared with empty vector controls"

  • Comparative ChIP analysis:

    • Analyze SIN3A recruitment to repressed vs. activated promoters

    • Examine co-recruitment with different binding partners (repressive vs. activating complexes)

    • Study histone modifications associated with SIN3A binding sites (e.g., H3K27 acetylation)

  • Protein complex analysis:

    • Use co-immunoprecipitation to identify SIN3A binding partners in different contexts

    • Perform mass spectrometry analysis of SIN3A complexes under different stimulation conditions

How can I investigate SIN3A's role in T-regulatory cell biology?

Based on recent research showing that "Sin3a plays a critical role in the maintenance of Treg identity and function and is essential for the expression and stability of Foxp3" , consider these approaches:

  • Genetic manipulation strategies:

    • Utilize conditional knockout models: Sin3a^fl/fl mice crossed with Foxp3^YFPcre to achieve Treg-specific deletion

    • For in vitro studies, consider CD4-specific deletion using Sin3a^-/-CD4^cre models

  • Functional assays:

    • Assess Treg suppressive capacity through in vitro suppression assays

    • Evaluate Foxp3 stability in the presence and absence of SIN3A

    • Monitor autoimmunity development in conditional knockout models

  • Molecular analyses:

    • Perform transcriptome profiling of SIN3A-deficient vs. control Tregs

    • Cross-reference DEGs with ATAC-seq data to identify chromatin accessibility changes

    • Investigate the chromatin landscape at key Treg signature genes

  • Technical considerations:

    • Plan experiments carefully as "Sin3a deletion in Tregs resulted in the development of autoimmunity" and "mice with homozygous deletion of Sin3a in Foxp3+ Tregs developed severe autoimmunity and died within 15–22 days of birth"

    • Consider alternative approaches like inducible deletion systems

What techniques can be used to study SIN3A's role in antiviral responses?

To investigate SIN3A's function in antiviral immunity, as indicated by research showing "Sin3a is required for basal and IFN-α–dependent transcription of several ISGs and, as a consequence, for efficient IFN-α–induced protection against viral infection" :

  • Viral infection models:

    • Influenza A virus (A/PR8/34, H1N1 subtype)

    • Hepatitis C virus (HCV)

    • Compare infection rates in control vs. SIN3A-depleted cells

  • Gene expression analysis:

    • Focus on interferon-stimulated genes (ISGs), particularly IFITM proteins

    • Compare basal and IFN-induced expression levels

  • Functional assays:

    • EROD activity assays for CYP1A1 function

    • Viral replication assays following IFN treatment

  • Mechanistic studies:

    • ChIP analysis of SIN3A recruitment to ISG promoters

    • Investigation of STAT1/STAT2/IRF9 (ISGF3) complex formation

    • Analysis of histone modifications at ISG promoters

How can I analyze SIN3A's interaction with STAT signaling pathways?

To study SIN3A's complex relationship with STAT signaling pathways:

  • STAT3 vs. ISGF3 regulation:

    • Compare SIN3A effects on STAT3-responsive genes vs. ISGF3-responsive genes

    • Analyze differential recruitment patterns through ChIP

    • Research indicates: "Sin3a complex represses STAT3 activity by modifying its acetylation status... Sin3a is instead required for IFN-stimulated gene (ISGs) transcription"

  • Protein-protein interaction studies:

    • Perform co-immunoprecipitation to identify direct interactions

    • Use proximity ligation assays to visualize interactions in situ

    • Employ mass spectrometry to identify complete interactomes

  • STAT3 nuclear dynamics:

    • Investigate SIN3A's effect on STAT3 nuclear localization

    • Research shows: "LIF-induced nuclear residence time of STAT3 was prolonged in cells transfected with SIN3A-targeting siRNA"

  • Promoter recruitment dynamics:

    • Examine SIN3A and STAT3 co-recruitment to target promoters

Why might I observe inconsistent results with different SIN3A antibodies?

Inconsistent results with SIN3A antibodies may occur due to:

  • Epitope accessibility:

    • Different antibodies target distinct regions (N-terminal, middle, C-terminal)

    • Protein interactions or post-translational modifications may mask epitopes

    • SIN3A is known to undergo sumoylation which might affect antibody recognition

  • Antibody specificity:

    • Polyclonal antibodies may recognize different epitopes or have lot-to-lot variation

    • Confirm specificity using knockout/knockdown controls or with multiple antibodies targeting different epitopes

  • Context-dependent functions:

    • SIN3A forms different protein complexes in different cellular contexts

    • Results may vary depending on cell type, stimulation conditions, or experimental context

    • Consider SIN3A's dual role as both repressor and activator

  • Technical variables:

    • Optimize fixation conditions for immunostaining applications (crosslinking may mask epitopes)

    • For Western blotting, ensure complete transfer of high molecular weight proteins

    • For ChIP, optimize sonication and immunoprecipitation conditions

How should I interpret unexpected or contradictory results regarding SIN3A function?

When facing unexpected results regarding SIN3A function:

  • Consider dual functionality:

    • SIN3A has both repressive and activating functions depending on context

    • "Although most of the research on the Sin3a complex has focused on its role as a corepressor, increasing evidence suggests that Sin3a may also activate gene transcription"

  • Cell type-specific effects:

    • Function may vary between cell types

    • "The research described here clearly implicates the Sin3a complex as a cell-specific repressor of STAT3 activity"

  • Target gene dependency:

    • Effects may differ based on target gene context

    • Analyze SIN3A function on a gene-by-gene basis

    • Consider the chromatin context of different target genes

  • Interaction partner influence:

    • SIN3A effects depend on associated proteins

    • "Sin3a is a conserved multifunctional repressor protein complex that regulates gene transcription"

    • Different binding partners may yield different functional outcomes

  • Experimental validation strategies:

    • Confirm findings with multiple approaches (ChIP, RNA-seq, functional assays)

    • Use both loss-of-function and gain-of-function approaches

    • Consider temporal dynamics of SIN3A recruitment and function

What are the critical factors in analyzing SIN3A ChIP-seq data?

When analyzing SIN3A ChIP-seq data:

  • Peak characteristics:

    • Examine both promoter-proximal and enhancer binding sites

    • SIN3A binds both promoters and enhancers, as seen in the CYP1A1 gene where "TCDD induces the recruitment of SIN3A to both the CYP1A1 proximal promoter and the enhancer region"

  • Co-occurring factors:

    • Analyze co-binding with sequence-specific transcription factors

    • Look for differential co-binding patterns at activated vs. repressed sites

    • Consider interactions with REST, MXI1, and MAD-MAX at repressed sites

  • Chromatin signature correlations:

    • Correlate SIN3A binding with histone modifications:

      • H3K27ac enrichment at SIN3A-activated genes

      • Decreased acetylation at repressed sites

  • Functional annotation:

    • Perform pathway and gene ontology analysis of SIN3A targets

    • Separate analysis for SIN3A-repressed vs. SIN3A-activated genes

  • Integration with expression data:

    • Correlate SIN3A binding with gene expression changes upon SIN3A knockdown

    • Create comprehensive models of SIN3A's dual functionality

What are the emerging roles of SIN3A beyond transcriptional regulation?

Recent research has uncovered novel roles for SIN3A beyond classical transcriptional regulation:

  • Immune system regulation:

    • Critical role in Treg cell function and prevention of autoimmunity

    • "Sin3a plays a critical role in the maintenance of Treg identity and function and is essential for the expression and stability of Foxp3"

    • Essential for antiviral immune responses

  • Development and differentiation:

    • Required for cortical neuron differentiation and callosal axon elongation

    • Highly expressed in developing brain, particularly in ventricular zones of cortical regions

  • Circadian rhythm regulation:

    • "Involved in the control of the circadian rhythms"

    • "Required for the transcriptional repression of circadian target genes, such as PER1"

  • Cell cycle control:

    • "Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression"

  • Epigenetic regulation beyond HDAC recruitment:

    • Interacts with OGT (O-GlcNAc transferase) to repress transcription in parallel with histone deacetylation

What are the most promising methodologies for studying SIN3A function?

Cutting-edge approaches for investigating SIN3A include:

  • Advanced genomic techniques:

    • CUT&RUN/CUT&Tag for higher resolution mapping of SIN3A binding sites

    • HiChIP to connect SIN3A binding with 3D chromatin interactions

    • Single-cell approaches to understand cell-to-cell variability in SIN3A function

  • Proteomics approaches:

    • Proximity labeling techniques (BioID, APEX) to identify context-specific interaction partners

    • Cross-linking mass spectrometry to map structural details of SIN3A complexes

    • Interactome profiling (RIME) to identify protein complexes at specific genomic loci

  • Functional genomics:

    • CRISPR screens to identify genetic dependencies on SIN3A

    • Domain-specific mutations to dissect functions of specific protein interactions

    • Degron approaches for rapid, inducible protein depletion

  • Imaging techniques:

    • Live-cell imaging of SIN3A dynamics

    • Super-resolution microscopy to visualize SIN3A-containing complexes

    • FRAP (Fluorescence Recovery After Photobleaching) to study binding kinetics

  • Computational approaches:

    • Machine learning to predict SIN3A binding sites and functional outcomes

    • Network analysis to understand SIN3A's position in regulatory networks

    • Integration of multi-omics data to build comprehensive models of SIN3A function

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.